SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001104659-16-160414
Filing Date
2016-12-02
Accepted
2016-12-02 16:02:06
Documents
12

Document Format Files

Seq Description Document Type Size
1 S-3 a16-22161_1s3.htm S-3 519594
2 EX-4.10 a16-22161_1ex4d10.htm EX-4.10 9166
3 EX-5.1 a16-22161_1ex5d1.htm EX-5.1 26552
4 EX-12.1 a16-22161_1ex12d1.htm EX-12.1 41570
5 EX-23.1 a16-22161_1ex23d1.htm EX-23.1 2428
6 GRAPHIC g221611bwi001.jpg GRAPHIC 2305
7 GRAPHIC g221611bwi002.gif GRAPHIC 5474
8 GRAPHIC g221611bei001.jpg GRAPHIC 2305
9 GRAPHIC g221611kg01i001.gif GRAPHIC 336606
10 GRAPHIC g221611kg03i001.gif GRAPHIC 54127
11 GRAPHIC g221611bmi001.jpg GRAPHIC 2305
12 GRAPHIC g221611bmi002.gif GRAPHIC 5474
  Complete submission text file 0001104659-16-160414.txt   1163725
Mailing Address 53 FRONTAGE ROAD SUITE 220 HAMPTON NJ 08827
Business Address 53 FRONTAGE ROAD SUITE 220 HAMPTON NJ 08827 908-200-7500
Celldex Therapeutics, Inc. (Filer) CIK: 0000744218 (see all company filings)

IRS No.: 133191702 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-214882 | Film No.: 162031173
SIC: 2835 In Vitro & In Vivo Diagnostic Substances